PHARMAGEN, INC. Accounts Receivable
PHARMAGEN, INC. had Accounts Receivable of $325.78 thousand as of 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2014-05-15
- 2014-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $325.78K.
- 2013-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $367.85K.
- 2013-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $606.53K.
- 2013-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $647.35K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2014-03-31 | $325.78K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $367.85K 10-Q · filed 2014-05-15 |
| 2013-09-30 | $606.53K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $647.35K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $762.58K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $635.60K 10-K · filed 2014-03-31 |
| 2012-09-30 | $445.28K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $705.19K 10-Q/A · filed 2012-09-14 |
| 2012-03-31 | $223.64K 10-Q · filed 2012-06-11 |
| 2011-12-31 | $211.55K 10-K · filed 2013-04-01 |